HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Mania — Clinical Guidelines

Overview

Mania is a distinct period of abnormally and persistently elevated, expansive, or irritable mood, often accompanied by hyperactivity, racing thoughts, and impulsivity 5.

Diagnosis

Elevated mood and increased energy levels

Hyperactivity and pressured speech

Impulsivity and risky behavior

Insomnia or reduced need for sleep

Psychotic features may occur in severe cases 4

No specific diagnostic tests; clinical assessment crucial 5

Management

First-line treatments: Mood stabilizers (e.g., lithium, valproate) 5

Adjunctive treatments:

- Antipsychotics (e.g., atypical antipsychotics like quetiapine, aripiprazole) 5 - Cognitive-behavioral therapy (CBT) for maintenance 5

Specific considerations:

- Digoxin trial showed no efficacy in mania management 8 - No evidence supports corticosteroid use for mania treatment 1

Special Populations

Pregnancy: Hormone replacement therapy may trigger mania in late-life women 2

Comorbidities: Monitor for mania in patients on corticosteroids or experiencing significant stress/sleep deprivation 1 4

Elderly: Increased vigilance for mania triggered by hormonal changes or polypharmacy 2

Key Recommendations

Evaluate for potential triggers such as corticosteroid use, sleep deprivation, and hormonal changes in mania onset (Evidence: Moderate 1 4 2)

Consider mood stabilizers as first-line pharmacological treatment for mania (Evidence: Strong 5)

Monitor patients for mania in the context of hormone replacement therapy, particularly in postmenopausal women (Evidence: Weak 2)

References

1 De Bock M, Sienaert P. Corticosteroids and mania: A systematic review. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2024. link 2 Young RC, Moline M, Kleyman F. Hormone replacement therapy and late-life mania. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 1997. link 3 Brown DW. Abnormal fluctuations of acetylcholine and serotonin. Medical hypotheses 1993. link90011-e) 4 Wright JB. Mania following sleep deprivation. The British journal of psychiatry : the journal of mental science 1993. link 5 Ambelas A. Causable mania (reactive, puerperal, secondary, life event related). The development of an idea. Acta psychiatrica Scandinavica 1987. link 6 Naylor GJ, Smith AH, Bryce-Smith D, Ward NI. Elevated vanadium content of hair and mania. Biological psychiatry 1984. link 7 Coid J, Strang J. Mania secondary to procyclidine ("Kemadrin") abuse. The British journal of psychiatry : the journal of mental science 1982. link 8 Naylor GJ, Worrall EP, Watson Y, Dick P, Stewart M, Peet M. Trial of digoxin in mania. Lancet (London, England) 1975. link90119-1)

Mania